IDEAYA Biosciences, Inc. (Nasdaq:IDYA) has announced the closing of its underwritten public offering of 5,797,872 shares of its common stock at a public offering price of US$23.50 per share, before underwriting discounts and commissions, and pre-funded warrants to purchase 319,150 shares of common stock at a public offering price of US$23.4999 per pre-funded warrant, before […]
The post Latham & Watkins Advises IDEAYA Biosciences in Public Offering appeared first on Legal Desire Media and Insights.